Personnel Information

写真a

MASUKO Masayoshi


Title

Associate Professor

Mail Address

E-mail address

Campus Career 【 display / non-display

  • Niigata University University Medical and Dental Hospital, Assistant Professor, 2005.04 - 2013.03

  • Niigata University University Medical and Dental Hospital Bone Marrow Transplantation Division, Associate Professor, 2013.04 -

  • Niigata University Graduate School of Medical and Dental Sciences Biomedical Sciences, Associate Professor, 2013.04 -

  • Niigata University Graduate School of Medical and Dental Sciences Biological Functions and Medical Control, Associate Professor, 2013.04 -

Field of expertise (Grants-in-aid for Scientific Research classification) 【 display / non-display

  • Hematology

 

Papers 【 display / non-display

  • Manifestations of fulminant CD8 T-cell post-transplant lymphoproliferative disorder following the administration of rituximab for lymphadenopathy with a high level of Epstein-Barr Virus (EBV)replication after allogeneic hematopoietic stem cell transplantation., Tanaka T, Takizawa J, Miyakoshi S, Kozakai T, Fuse K, Shibasaki Y, Moriyama M,Ohshima K, Toba K, Furukawa T, Sone H, Masuko M. , Intern Med., 2014.09, English

    Research paper (scientific journal), Multiple Authorship

  • Genetic variants in C5 and poor response to eculizumab., Kitamura K, Eto T, Takahashi T, Masuko M, Matsumoto T, Wano Y, Shichishima T, Shibayama H, Hase M, Li L, Johnson K, Lazarowski A, Tamburini P, Inazawa J, Kinoshita T, Kanakura Y., N Engl J Med., 2014.02, English

    Research paper (scientific journal), Multiple Authorship

  • Ustekinumab improves psoriasis without suppressing tumor antigen-specific cytotoxic T lymphocytes. , Narita M, Nishizawa Y, Iwaya S, Oiwa E, Iwabuchi M, Uchiyama T, Matsuyama A, Masuko M, Takahashi M., Int Arch Allergy Immunol., 2014.01, English

    Research paper (scientific journal), Multiple Authorship

  • Successful treatment of severe newly diagnosed immune thrombocytopenia involving an alveolar hemorrhage with combination therapy consisting of romiplostim, rituximab and vincristine. , Okazuka K, Masuko M, Matsuo Y, Miyakoshi S, Tanaka T, Kozakai T, Kobayashi H,  Fuse K, Shibasaki Y, Moriyama M, Takizawa J, Fuse I, Toba K, Furukawa T., Intern Med, 2013.11, English

    Research paper (scientific journal), Multiple Authorship

  • Hypocellularity and insufficient expression of angiogenic factors in implanted autologous bone marrow in patients with chronic critical limb ischemia. , Oda M, Toba K, Kato K, Ozawa T, Yanagawa T, Ikarashi N, Takayama T, Suzuki T, Hanawa H, Masuko M, Kobayashi H, Aizawa Y., Heart Vessels., 2012.01, English

    Research paper (scientific journal), Multiple Authorship

display all >>